DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Armour Thyroid (Thyroid) - Summary



ArmourĀ® Thyroid (thyroid tablets, USP) for oral use is a natural preparation derived from porcine thyroid glands and has a strong, characteristic odor. (T3 liothyronine is approximately four times as potent as T4 levothyroxine on a microgram for microgram basis.) They provide 38 mcg levothyroxine (T4) and 9 mcg liothyronine (T3) per grain of thyroid. The inactive ingredients are calcium stearate, dextrose, microcrystalline cellulose, sodium starch glycolate and opadry white.

Armour Thyroid tablets are indicated:

  1. As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. This category includes cretinism, myxedema, and ordinary hypothyroidism in patients of any age (children, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary), or tertiary (hypothalamic) hypothyroidism (See WARNINGS).
  2. As pituitary TSH suppressants, in the treatment or prevention of various types of euthyroid goiters, including thyroid nodules, subacute or chronic Iymphocytic thyroiditis (Hashimoto's), multinodular goiter, and in the management of thyroid cancer.

See all Armour Thyroid indications & dosage >>


Media Articles Related to Armour Thyroid (Thyroid)

Medullary Thyroid Cancer Surgical Recommendations Often Ignored
Source: Medscape Diabetes & Endocrinology Headlines [2017.09.29]
Preventive nodal dissection in medullary thyroid cancer is uncommon, despite American Thyroid Association recommendations.
Medscape Medical News

TSH Levels Linked to Papillary Thyroid Cancer, With Sex Differences
Source: Medscape Diabetes & Endocrinology Headlines [2017.09.28]
Low levels in women, high levels in men, associated with a higher risk of papillary thyroid cancer.
Medscape Medical News

Thyroid Disorders
Source: MedicineNet Hair Loss Specialty [2017.09.27]
Title: Thyroid Disorders
Category: Diseases and Conditions
Created: 3/16/2009 12:00:00 AM
Last Editorial Review: 9/27/2017 12:00:00 AM

Thyroid Quiz: Test Your Medical IQ
Source: MedicineNet Hyperparathyroidism Specialty [2017.09.19]
Title: Thyroid Quiz: Test Your Medical IQ
Category: MedicineNet Quiz
Created: 7/22/2011 2:10:00 PM
Last Editorial Review: 9/19/2017 6:42:22 PM

Thyroid Problems May Make Things Worse for Dialysis Patients
Source: MedicineNet Hypothyroidism Specialty [2017.07.14]
Title: Thyroid Problems May Make Things Worse for Dialysis Patients
Category: Health News
Created: 7/13/2017 12:00:00 AM
Last Editorial Review: 7/14/2017 12:00:00 AM

more news >>

Published Studies Related to Armour Thyroid (Thyroid)

Vandetanib for the treatment of medullary thyroid carcinoma. [2014]
CONCLUSIONS: Vandetanib prolongs PFS but has not been shown to improve OS.

Does corticosteroid have any beneficial effect on voice change after thyroidectomy? [2013]
Voice alteration is one of the most common complications after thyroidectomy...

Vandetanib: a novel targeted therapy for the treatment of metastatic or locally advanced medullary thyroid cancer. [2013]
CONCLUSION: Vandetanib has been shown to be more effective than placebo in the

Treatment of iron-deficiency anemia in patients with subclinical hypothyroidism. [2013]
be superior to each treatment alone... CONCLUSION: Subclinical hypothyroidism was investigated in iron-deficient

Vandetanib: in medullary thyroid cancer. [2012]
Vandetanib, an orally active, small-molecule, multitargeted tyrosine kinase inhibitor, demonstrates potent inhibitory activity against vascular endothelial growth factor receptor (VEGFR)-2 and -3, epidermal growth factor receptor (EGFR) and the rearranged during transfection (RET) tyrosine kinase receptor...

more studies >>

Clinical Trials Related to Armour Thyroid (Thyroid)

ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer [Completed]
The purpose of this study is to determine whether TOK-001 is safe and shows biological effect in the treatment of castration resistant prostate cancer (CRPC).

Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment [Recruiting]
The purpose of this study is to better understand how effective ablation is for destroying tumor cells in the kidney and whether quality of life is improved for patients. Participation in ARMOR may involve retrospective data collection only, combined retrospective and prospective data collection, or prospective data collection

A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC [Recruiting]

A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer [Active, not recruiting]

Diagnostic Algorithm in Suspected Upper Extremity Deep Vein Thrombosis [Completed]
Deep vein thrombosis (DVT) of the arm, officially called upper extremity DVT is a rare disorder and accounts for up to 1-4% of all cases of deep vein thrombosis. In case of a thrombosis, there is a blood clot in one of the veins, which should be treated with blood thinners (anticoagulants). The aim of the present study is to see whether it is safe to use a combination of tests for the diagnosis of arm thrombosis. In all patients, we will use a clinical decision rule (clinical judgement) and a laboratory test (D-dimer testing), in most patients also an ultrasound of the arm will be done. The combination of these tests was found to be safe and effective in patients with thrombosis of the legs.

more trials >>

Page last updated: 2017-09-29

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017